Mark Jones, MD
Foot and Ankle Surgery · North Chesterfield, VANPI 1871536235
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $2,043,018 of the $2,377,893 with a category attached, or 85.9%. Medtronic accounts for 99.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $2,043,844 and has fallen 99.7% since, to $6,094 in 2025. Among foot and ankle surgery clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 39 payments — averaging $60,972 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2.4M
- Medical Device Business Services, Inc.$1K
- Stryker$571
- Davol Inc.$294
- Johnson & Johnson$213
- Fortis Surgical, LLC$99
What the payments were for
- Royalty or licence$2,043,01886%
- Travel & lodging$8240%
- Food & beverage$1,4540%
- Other$332,59614%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 20 | $2,375,614 |
| Medical Device Business Services, Inc. | 7 | $1,102 |
| Stryker | 5 | $571 |
| Davol Inc. | 3 | $294 |
| Johnson & Johnson | 3 | $213 |
| Fortis Surgical, LLC | 1 | $99 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ellipsys$2,291,664
- ELLIPSYS VASCULAR ACCESS SYSTEM$83,950
- ATTUNE$1,092
- ACTIS$824
- ARISTA AH FLEXITIP$243
- HOFFMANN$150
- Velys$147
- AXSOS$142
- ANCHORAGE$141
- STRYKER NAV3I$123
How this compares
$2,377,893 in reported general payments places this provider in the 95th percentile of 260 foot and ankle surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 46 | $1,754 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $350 |
| Gabapentin | 43 | $279 |
| Oxycodone Hcl | 34 | $253 |
| Mupirocin | 33 | $231 |
| Amoxicillin | 117 | $137 |
| Meloxicam | 46 | $117 |
| Methylprednisolone | 14 | $112 |
| Tramadol Hcl | 41 | $101 |
| Cephalexin | 25 | $100 |
| Clindamycin Hcl | 26 | $81 |
| Ondansetron Hcl | 12 | $70 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in North Chesterfield
- Robert PicaNorth Chesterfield$76K
- Oliver SchipperArlington$1.2M
- Steven NeufeldFalls Church$857K
- Charles ZelenRoanoke$363K
- Ryan VazalesGlen Allen$337K
- Jugal DhariaFairfax$309K
- William SimonVirginia Beach$292K
- William GrantVirginia Beach$271K
- Bradley LevittVirginia Beach$243K
- Richard DernerLake Ridge$212K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.